1-4 of 4
Wei Hao
Close
Sort by
Journal Articles

CRISPR/dCas9 (D10A) -Mediated Hb CS Gene Editing and Identification of Genetically Modified Fibroblasts

Lian Yu, Wei Hao Wu, WANG Shunqing, Ken H. Young, Funeng Jiang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5754.
https://doi.org/10.1182/blood-2019-129931
Published: 2019
Journal Articles

Low-Dose Interleukin-2 Restores Human Regulatory T Cell Function, in Vitro , As a Potential in the Handle of Graft Versus Host Disease (GvHD)

Tzeon-Jye Chiou, MD, Hsiu-Hsia Lin, PhD, Wei-Hao Wu, BS, Jhih-Yun Jian, MS, Sin-Tak Chu, PhD, Woan-Fang Tzeng, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5450.
https://doi.org/10.1182/blood.V130.Suppl_1.5450.5450
Published: 2017
Journal Articles

Expansion and Reactivation of Human Naïve T-Cells Transition into CD4+CD25+FoxP3+CD127-Regulatory T Cells, In Vitro , for the Potential Use of Graft-Versus-Host Disease Prevention

Tzeon-Jye Chiou, MD, Tien-Hua Chu, PhD, Wei-Hao Wu, MS, Sin-Tak Chu, PhD, Woan-Fang Tzeng, PhD
Journal: Blood
Blood (2016) 128 (22): 5729.
https://doi.org/10.1182/blood.V128.22.5729.5729
Published: 2016
Journal Articles

In Vivo Phycocyanin Treatment of S180 Bearing-Mice: Increase in Immunic Function and Inhibition of Tumor Growth.

Ling Pan, Wei Hao, Xuejun Zhang, Zhiyun Niu, Fuxu Wang, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 5191.
https://doi.org/10.1182/blood.V108.11.5191.5191
Published: 2006